Affiliation:
1. Thrombosis Service, Department of Laboratory of Clinical Chemistry and Haematology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands
2. Thrombosis Service and Contract Research, Departments of Stichting Huisartsen Laboratorium, Etten-Leur, The Netherlands
3. Haemostasis and Thrombosis Research Center, Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands
Abstract
Abstract
Background: The quality of oral anticoagulant therapy management with coumarin derivatives requires reliable results for the prothrombin time/International Normalized Ratio (PT/INR). We assessed the effect on PT/INR of preanalytical variables, including ones related to off-site blood collection and transportation to a laboratory.
Methods: Four laboratories with different combinations of blood collection systems, thromboplastin reagents, and coagulation meters participated. The simulated preanalytical variables included time between blood collection and PT/INR determinations on samples stored at room temperature, at 4–6 °C, and at 37 °C; mechanical agitation at room temperature, at 4–6 °C, and at 37 °C; time between centrifugation and PT/INR determination; and times and temperatures of centrifugation. For variables that affected results, the effect of the variable was classified as moderate when <25% of samples showed a change >10% or as large if >25% of samples showed such a change.
Results: During the first 6 h after blood collection, INR changed by >10% in <25% of samples (moderate effect) when blood samples were stored at room temperature, 4–6 °C, or 37 °C with or without mechanical agitation and independent of the time of centrifugation after blood collection. With one combination of materials and preanalytical conditions, a 24-h delay at room temperature or 4–6 °C had a large effect, i.e., changes >10% in >25% of samples. In all laboratories, a 24-h delay at 37 °C or with mechanical agitation had a large effect. We observed no clinically or statistically relevant INR differences among studied centrifugation conditions (centrifugation temperature, 20 °C or no temperature control; centrifugation time, 5 or 10 min).
Conclusions: We recommend a maximum of 6 h between blood collection and PT/INR determination. The impact of a 24-h delay should be investigated for each combination of materials and conditions.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Reference20 articles.
1. Rosendaal FR, Cannegieter SC, van der Meer FJM, Briët E. A method to determine the optimal intensity of oral anticoagulation therapy. Thromb Haemost1993;39:236-239.
2. Van Geest-Daalderop JHH, Sturk A, Levi M, Adriaansen HJ. Omvang en kwaliteit van de antistollingsbehandeling met cumarinederivaten door de Nederlandse trombosediensten. Ned Tijdschr Geneeskd2004;148:730-735.
3. . WHO Expert Committee on Biological Standardization. Requirements for thromboplastins and plasmas used to control oral anticoagulant therapy. 33rd report. World Health Organ Tech Rep Ser1983;687:81-105.
4. Loeliger EA, van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the prothrombin times in oral anticoagulant control. Thromb Haemost1985;53:148-154.
5. Poller L. International Normalized Ratios (INR): 20 years. J Thromb Haemost2004;2:849-860.